| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
5,420 |
4,156 |
$192K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
10,906 |
8,338 |
$185K |
| 70450 |
Computed tomography, head or brain; without contrast material |
2,611 |
2,110 |
$178K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
1,729 |
1,433 |
$150K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
15,477 |
11,872 |
$126K |
| 71046 |
Radiologic examination, chest; 2 views |
6,035 |
4,336 |
$109K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
7,226 |
2,158 |
$87K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
3,599 |
2,889 |
$74K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
570 |
474 |
$59K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
4,585 |
3,909 |
$55K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
6,390 |
5,242 |
$45K |
| 71045 |
Radiologic examination, chest; single view |
2,652 |
2,257 |
$44K |
| 71250 |
|
515 |
328 |
$42K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
5,007 |
3,974 |
$32K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
3,214 |
2,765 |
$32K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
9,300 |
3,080 |
$22K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
4,523 |
3,584 |
$19K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
2,399 |
1,944 |
$17K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
1,733 |
656 |
$16K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
3,717 |
3,353 |
$14K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
217 |
205 |
$14K |
| 80053 |
Comprehensive metabolic panel |
17,440 |
14,419 |
$14K |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
1,578 |
1,283 |
$13K |
| 96376 |
|
1,824 |
1,398 |
$11K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
18,477 |
14,787 |
$11K |
| 73560 |
|
537 |
398 |
$10K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
876 |
667 |
$9K |
| 73030 |
|
469 |
313 |
$9K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
2,003 |
1,857 |
$8K |
| 20610 |
|
778 |
379 |
$7K |
| 94060 |
|
346 |
205 |
$7K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
1,238 |
1,174 |
$7K |
| 72100 |
|
231 |
192 |
$6K |
| 94729 |
|
336 |
194 |
$6K |
| 73630 |
|
629 |
500 |
$6K |
| 84443 |
Thyroid stimulating hormone (TSH) |
4,436 |
4,264 |
$5K |
| 94726 |
|
258 |
147 |
$5K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
49 |
49 |
$5K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
1,290 |
1,218 |
$5K |
| 83735 |
|
7,877 |
6,192 |
$5K |
| 73610 |
|
518 |
378 |
$5K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
491 |
186 |
$4K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
1,421 |
1,139 |
$4K |
| 84484 |
|
5,028 |
4,041 |
$4K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
3,104 |
2,738 |
$4K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
201 |
181 |
$4K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
3,357 |
3,257 |
$3K |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
435 |
340 |
$3K |
| 73502 |
|
127 |
109 |
$3K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
25 |
24 |
$3K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
272 |
216 |
$3K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
2,611 |
2,245 |
$3K |
| 36415 |
Collection of venous blood by venipuncture |
23,798 |
17,215 |
$3K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
136 |
88 |
$2K |
| 97162 |
|
120 |
117 |
$2K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
429 |
414 |
$2K |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
5,023 |
4,362 |
$2K |
| 83880 |
|
1,994 |
1,758 |
$2K |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
287 |
258 |
$2K |
| 73110 |
|
175 |
99 |
$2K |
| 82728 |
|
1,487 |
1,421 |
$2K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
1,635 |
1,579 |
$2K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
2,705 |
2,207 |
$2K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
64 |
64 |
$1K |
| 73130 |
|
107 |
76 |
$1K |
| 99291 |
Critical care, evaluation and management of the critically ill patient, first 30-74 minutes |
33 |
25 |
$1K |
| 81000 |
|
3,627 |
3,298 |
$1K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
761 |
720 |
$1K |
| 83605 |
|
2,952 |
2,569 |
$1K |
| 83550 |
|
1,285 |
1,235 |
$1K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
1,613 |
1,527 |
$1K |
| 87040 |
|
1,724 |
1,530 |
$1K |
| 82803 |
|
1,897 |
1,544 |
$1K |
| 83540 |
|
1,384 |
1,330 |
$1K |
| 96367 |
|
176 |
148 |
$1K |
| 73721 |
Magnetic resonance imaging, any joint of lower extremity; without contrast material |
13 |
12 |
$1K |
| 85610 |
|
3,523 |
2,064 |
$1K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
2,573 |
2,370 |
$977.51 |
| J2060 |
Injection, lorazepam, 2 mg |
534 |
406 |
$965.02 |
| 82607 |
|
990 |
958 |
$843.97 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
184 |
131 |
$834.18 |
| 84439 |
|
648 |
625 |
$797.93 |
| 83690 |
|
3,195 |
2,796 |
$786.77 |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
2,826 |
2,054 |
$762.27 |
| 80061 |
Lipid panel |
3,656 |
3,579 |
$755.07 |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
2,006 |
771 |
$734.40 |
| 99239 |
Hospital discharge day management, more than 30 minutes |
46 |
41 |
$692.83 |
| 86140 |
|
2,262 |
2,099 |
$626.32 |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
96 |
38 |
$598.33 |
| 85379 |
|
981 |
945 |
$596.51 |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
98 |
95 |
$541.76 |
| 76641 |
|
24 |
12 |
$541.74 |
| 90715 |
|
13 |
12 |
$501.03 |
| 82570 |
|
1,033 |
975 |
$498.42 |
| 82962 |
|
2,205 |
1,503 |
$472.32 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
568 |
535 |
$388.98 |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
302 |
237 |
$378.34 |
| 85027 |
|
815 |
761 |
$372.66 |
| 94618 |
|
25 |
15 |
$372.40 |
| 81002 |
|
3,686 |
3,410 |
$363.09 |
| 74018 |
|
41 |
41 |
$322.67 |
| 87186 |
|
554 |
524 |
$314.94 |
| 87088 |
|
421 |
409 |
$312.49 |
| 87077 |
|
1,273 |
1,180 |
$309.79 |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
289 |
280 |
$301.15 |
| 80306 |
|
1,969 |
1,792 |
$259.03 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
154 |
152 |
$248.59 |
| 81001 |
|
337 |
322 |
$235.84 |
| 76536 |
|
12 |
12 |
$228.70 |
| 73562 |
|
16 |
13 |
$218.40 |
| 82043 |
|
372 |
361 |
$208.90 |
| 85730 |
|
388 |
303 |
$203.13 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
126 |
118 |
$198.20 |
| 84481 |
|
78 |
77 |
$158.38 |
| 85652 |
|
742 |
710 |
$155.53 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
78 |
73 |
$148.14 |
| 97161 |
|
14 |
14 |
$128.63 |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
283 |
272 |
$124.66 |
| 81003 |
|
302 |
290 |
$105.04 |
| 84100 |
|
132 |
127 |
$101.74 |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
1,157 |
737 |
$90.33 |
| 92508 |
Group treatment of speech, language, voice, communication, and/or auditory processing disorder |
425 |
203 |
$72.17 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
13 |
12 |
$71.23 |
| 81025 |
|
1,358 |
1,285 |
$62.18 |
| 84403 |
|
24 |
24 |
$54.94 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
611 |
593 |
$42.52 |
| 85008 |
|
712 |
627 |
$36.78 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
518 |
499 |
$34.36 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
17 |
13 |
$34.22 |
| A9270 |
Non-covered item or service |
757 |
649 |
$28.39 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
30 |
28 |
$26.26 |
| 86803 |
|
52 |
50 |
$24.67 |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
135 |
128 |
$15.57 |
| 84311 |
|
50 |
48 |
$10.33 |
| 87081 |
|
269 |
256 |
$6.45 |
| 83986 |
|
49 |
47 |
$5.48 |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
13 |
13 |
$5.16 |
| 84702 |
|
29 |
24 |
$4.06 |
| 84550 |
|
13 |
12 |
$0.53 |
| G8979 |
Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
128 |
119 |
$0.01 |
| 85007 |
|
83 |
78 |
$0.00 |
| G8978 |
Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals |
108 |
101 |
$0.00 |
| 97533 |
|
33 |
15 |
$0.00 |
| 77080 |
|
24 |
12 |
$0.00 |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
30 |
30 |
$0.00 |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
29 |
29 |
$0.00 |
| 87807 |
|
26 |
26 |
$0.00 |
| 86901 |
|
13 |
12 |
$0.00 |
| 82550 |
|
13 |
12 |
$0.00 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
30 |
30 |
$0.00 |